Emtricitabine is a nucleoside reverse transcriptase inhibitor used in HIV treatment, while its sulfoxide derivative is a key oxidative degradation product. This metabolite is relevant for in vitro stability studies and pharmacokinetic research, aiding in the investigation of drug metabolism and impurity profiling.